EMFLAZA 36 mg/1
deflazacort · TABLET · PTC Therapeutics, Inc.
No Recall History
Plain English
Emflaza is a prescription corticosteroid tablet taken by mouth that is used to treat muscular dystrophy. Each tablet contains 36 mg of the active ingredient deflazacort.
Key Facts
- Brand Name
- EMFLAZA
- Generic Name
- deflazacort
- NDC Code (Product)
52856-504- Manufacturer
- PTC Therapeutics, Inc.
- Strength
- 36 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- NDA208684
- Drug Class
- Corticosteroid [EPC]
- Marketing Start
- 09/10/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is EMFLAZA used for?
Emflaza is a prescription corticosteroid tablet taken by mouth that is used to treat muscular dystrophy. Each tablet contains 36 mg of the active ingredient deflazacort.
Is EMFLAZA a controlled substance?
EMFLAZA is not classified as a controlled substance by the DEA.
What is the generic name for EMFLAZA?
The generic name for EMFLAZA is deflazacort. There are 10 other brand versions of deflazacort.
What is the NDC code for EMFLAZA 36 mg/1?
The NDC (National Drug Code) for EMFLAZA 36 mg/1 is 52856-504, listed by PTC Therapeutics, Inc..